GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » EV-to-EBIT

PW Medtech Group (HKSE:01358) EV-to-EBIT : -0.67 (As of Jun. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PW Medtech Group's Enterprise Value is HK$-169.1 Mil. PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil. Therefore, PW Medtech Group's EV-to-EBIT for today is -0.67.

The historical rank and industry rank for PW Medtech Group's EV-to-EBIT or its related term are showing as below:

HKSE:01358' s EV-to-EBIT Range Over the Past 10 Years
Min: -2.22   Med: 15.06   Max: 47.37
Current: -0.35

During the past 12 years, the highest EV-to-EBIT of PW Medtech Group was 47.37. The lowest was -2.22. And the median was 15.06.

HKSE:01358's EV-to-EBIT is ranked better than
99.11% of 451 companies
in the Medical Devices & Instruments industry
Industry Median: 19.75 vs HKSE:01358: -0.35

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PW Medtech Group's Enterprise Value for the quarter that ended in Dec. 2023 was HK$394.8 Mil. PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil. PW Medtech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 64.06%.


PW Medtech Group EV-to-EBIT Historical Data

The historical data trend for PW Medtech Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group EV-to-EBIT Chart

PW Medtech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.09 1.84 -1.53 1.22 1.56

PW Medtech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.53 - 1.22 - 1.56

Competitive Comparison of PW Medtech Group's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, PW Medtech Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's EV-to-EBIT falls into.



PW Medtech Group EV-to-EBIT Calculation

PW Medtech Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-169.080/252.904
=-0.67

PW Medtech Group's current Enterprise Value is HK$-169.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group  (HKSE:01358) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PW Medtech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=252.904/394.8106
=64.06 %

PW Medtech Group's Enterprise Value for the quarter that ended in Dec. 2023 was HK$394.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group (HKSE:01358) Business Description

Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Executives
Right Faith Holdings Limited 2101 Beneficial owner
Chan Marc 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Cross Mark Limited 2101 Beneficial owner
Liu Yufeng 2201 Interest of corporation controlled by you
Zhang Zaixian 2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines